Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Turrini

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Gaceta Sanitaria|April 22, 2026
Patient and public involvement in health technology assessments: study protocol for a cross-sectional analysisFerrán Catalá-López, Ernesto Ganuza, Constance Colin, et al.
Journal of Geriatric Oncology|October 24, 2020
Validation of the "fitness criteria" for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL)Erika Borlenghi, Chiara Pagani, Patrizia Zappasodi, et al.
Pharmacogenomics and Personalized Medicine|May 2, 2022
Therapeutic Management of Patients with FLT3 + Acute Myeloid Leukemia: Case Reports and Focus on Gilteritinib MonotherapyMonica Bocchia, Angelo Michele Carella, Antonino Mulè, et al.
Haematologica|March 10, 2022
Extracellular vesicles mediate the communication between multiple myeloma and bone marrow microenvironment in a NOTCH dependent wayDomenica Giannandrea, Natalia Platonova, Michela Colombo, et al.
Haematologica|October 5, 2019
Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistanceMichela Colombo, Silvia Garavelli, Mara Mazzola, et al.
Cancers|January 23, 2024
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination-Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica LombardaGiuseppe Rossi, Erika Borlenghi, Patrizia Zappasodi, et al.
American Journal of Hematology|November 23, 2017
Secondary acute myeloid leukaemia in elderly patients: Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions. An analysis of 280 patients by the network rete ematologica lombarda (REL)Erika Borlenghi, Chiara Pagani, Patrizia Zappasodi, et al.
British Journal of Haematology|July 30, 2022
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 studyVincenzo Marasco, Alfonso Piciocchi, Anna Candoni, et al.
European Journal of Haematology|June 17, 2021
Nilotinib-induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-Chronic Myeloid Leukemia: Final report of the PhilosoPhi34 studyEster Pungolino, Mariella D'adda, Gabriella De Canal, et al.
Cancers|March 28, 2025
Bone Marrow CD34+/lin- Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) After 12 Months of Nilotinib Treatment Exhibit a Different Gene Expression Signature Compared to the Diagnosis and the Corresponding Cells from Healthy SubjectsAlessandra Trojani, Ester Pungolino, Barbara Di Camillo, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Gaceta Sanitaria|April 22, 2026
Patient and public involvement in health technology assessments: study protocol for a cross-sectional analysisFerrán Catalá-López, Ernesto Ganuza, Constance Colin, et al.
Journal of Geriatric Oncology|October 24, 2020
Validation of the "fitness criteria" for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL)Erika Borlenghi, Chiara Pagani, Patrizia Zappasodi, et al.
Pharmacogenomics and Personalized Medicine|May 2, 2022
Therapeutic Management of Patients with FLT3 + Acute Myeloid Leukemia: Case Reports and Focus on Gilteritinib MonotherapyMonica Bocchia, Angelo Michele Carella, Antonino Mulè, et al.
Haematologica|March 10, 2022
Extracellular vesicles mediate the communication between multiple myeloma and bone marrow microenvironment in a NOTCH dependent wayDomenica Giannandrea, Natalia Platonova, Michela Colombo, et al.
Haematologica|October 5, 2019
Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistanceMichela Colombo, Silvia Garavelli, Mara Mazzola, et al.
Cancers|January 23, 2024
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination-Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica LombardaGiuseppe Rossi, Erika Borlenghi, Patrizia Zappasodi, et al.
American Journal of Hematology|November 23, 2017
Secondary acute myeloid leukaemia in elderly patients: Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions. An analysis of 280 patients by the network rete ematologica lombarda (REL)Erika Borlenghi, Chiara Pagani, Patrizia Zappasodi, et al.
British Journal of Haematology|July 30, 2022
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 studyVincenzo Marasco, Alfonso Piciocchi, Anna Candoni, et al.
European Journal of Haematology|June 17, 2021
Nilotinib-induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-Chronic Myeloid Leukemia: Final report of the PhilosoPhi34 studyEster Pungolino, Mariella D'adda, Gabriella De Canal, et al.
Cancers|March 28, 2025
Bone Marrow CD34+/lin- Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) After 12 Months of Nilotinib Treatment Exhibit a Different Gene Expression Signature Compared to the Diagnosis and the Corresponding Cells from Healthy SubjectsAlessandra Trojani, Ester Pungolino, Barbara Di Camillo, et al.
Pageof 6